New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
08:41 EDTROSGRosetta Genomics announces Alzheimer's agreement with global pharma company
Rosetta Genomics announces that it has signed an agreement with a global pharmaceutical company, or GPC, in the area of Alzheimer's disease, or AD, diagnostics. Under the agreement, Rosetta will provide its microRNA profiling and other services to assist in the development of a microRNA-based diagnostic for the early detection of AD. Rosetta will leverage the GPC's expertise in AD as it is considered a pioneer in the development and commercialization of therapeutics for AD.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 24, 2014
10:03 EDTROSGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:36 EDTROSGRosetta Genomics initiated with a Hold at Cantor
Subscribe for More Information
October 23, 2014
08:14 EDTROSGRosetta announces presentation of microRNA-based thyroid cancer assay
Subscribe for More Information
October 21, 2014
08:18 EDTROSGRosetta Genomics announces partnership with IMTM
Subscribe for More Information
October 13, 2014
08:43 EDTROSGBiocept, Rosetta Genomics collaborate to evaluate microRNAs from CTCs
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use